Drug Shortages: Legislation and Proposed Regulatory Actions

IPD has released a new report, "Drug Shortages: Legislation and Proposed Regulatory Actions," which delves into the increasing number of drug shortages affecting both hospitals and retail pharmacies. The report highlights key legislative actions and federal proposals aimed at addressing this critical issue.

Key points include:
A record 323 active drug shortages were tracked by ASHP in the first quarter of 2024.

Federal actions to address drug shortages include the PREPARE Act, Pediatric Cancer Drug Supply Act, White House Council on Supply Chain Resilience, and FTC investigation into GPO practices.

Other proposals include incentives for hospitals to maintain a buffer stock of essential medications.

Content on this site is proprietary to IPD Analytics. By receiving this sample you are agreeing to refrain from any unauthorized use, including uploading or inputting into AI tools or large language models for any purpose, is strictly prohibited.